Who are DOMIPHEN BROMIDE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Povidone Iodine Topical, Pre-Op, POVIDONE, Chlorhexidine 0.2% Mouthrinse, ChloraPrep One-Step, Chlorhexidine Gluconate (CHG).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/domiphen-bromide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

DOMIPHEN BROMIDE — Competitive Intelligence Brief

DOMIPHEN BROMIDE (DOMIPHEN BROMIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiseptic. Area: Metabolic.

marketed Antiseptic Microbial cell membranes Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

DOMIPHEN BROMIDE (DOMIPHEN BROMIDE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DOMIPHEN BROMIDE TARGET	DOMIPHEN BROMIDE		marketed	Antiseptic	Microbial cell membranes
Povidone Iodine Topical	Povidone Iodine Topical	Mary K Hayden	marketed	Topical antiseptic/disinfectant	Microbial cell membranes and proteins (non-selective)
Pre-Op	HEXACHLOROPHENE	Davis And Geck	marketed	Antiseptic	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, 78 kDa glucose-regulated protein, Adenosine receptor A3	1949-01-01
POVIDONE	POVIDONE		marketed	Antiseptic [EPC]
Chlorhexidine 0.2% Mouthrinse	Chlorhexidine 0.2% Mouthrinse	University of Oslo	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
ChloraPrep One-Step	ChloraPrep One-Step	C. R. Bard	marketed	Topical antiseptic
Chlorhexidine Gluconate (CHG)	Chlorhexidine Gluconate (CHG)	University of Pennsylvania	marketed	Antimicrobial agent / Antiseptic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiseptic class)

· 1 drug in this class
Davis And Geck · 1 drug in this class
The Dial Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DOMIPHEN BROMIDE — Competitive Intelligence Brief. https://druglandscape.com/ci/domiphen-bromide. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab